Sorry, you need to enable JavaScript to visit this website.
Clinical Study Reports (CSRs) are often created as part of the process of submitting applications for new medical treatments to regulators. CSRs answer questions such as: Why was the trial done? What were the important questions asked in the trial? What were the results? CSRs also include extensive details on the course of treatment for patients, the medical information collected from the patients as part of the research, and demographic data, as well as other kinds of information to explain how the trial was conducted and results were analyzed.

Because CSRs contain information that could be valuable to researchers, Pfizer is making electronic synopses of CSRs publicly available on this website. They include the synopsis of the CSR submitted to the regulatory agency.

Any data that could be used to identify individual patients has been removed.  Synopses will be posted for trials either initiated after Sept. 27, 2007, or trials initiated on or before that date that were still ongoing as of Dec. 26, 2007. To access the synopses that have been posted to date, press the "Show Results" button to see the full list, or filter the results using the fields below.

 

 

E.g., 2020-01-24
E.g., 2020-01-24
E.g., 2020-01-24
E.g., 2020-01-24
Select any filter and click on Apply to see results

* The NCT Number is the ClinicalTrials.gov unique identifier for a specific study.

Pfizer’s practices adhere to the principles for responsible data sharing laid out by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA).